Go Pro

Flowers Foods (FLO) Financials

Flowers Foods logo
$6.18 -0.14 (-2.14%)
As of 03:25 PM Eastern
This is a fair market value price provided by Massive. Learn more.
Annual Income Statements for Flowers Foods

Annual Income Statements for Flowers Foods

This table shows Flowers Foods' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Income / (Loss) Attributable to Common Shareholders
189 164 150 157 165 152 206 228 123 248 84
Consolidated Net Income / (Loss)
189 164 150 157 165 152 206 228 123 248 84
Net Income / (Loss) Continuing Operations
189 164 150 157 165 152 206 228 123 248 84
Total Pre-Tax Income
293 250 149 197 212 201 271 299 157 329 115
Total Operating Income
298 258 156 212 225 321 295 303 173 348 174
Total Gross Profit
1,815 1,900 1,911 1,885 1,968 2,192 2,156 2,304 2,459 2,526 2,569
Total Revenue
3,779 3,927 3,921 3,952 4,124 4,388 4,331 4,806 5,091 5,103 5,256
Operating Revenue
3,779 3,927 3,921 3,952 4,124 4,388 4,331 4,806 5,091 5,103 5,256
Total Cost of Revenue
1,963 2,027 2,009 2,067 2,156 2,196 2,175 2,502 2,632 2,577 2,688
Operating Cost of Revenue
1,963 2,027 2,009 2,067 2,156 2,196 2,175 2,502 2,632 2,577 2,688
Total Operating Expenses
1,517 1,642 1,755 1,673 1,743 1,870 1,861 2,001 2,286 2,178 2,395
Selling, General & Admin Expense
1,382 1,469 1,510 1,507 1,575 1,693 1,720 1,851 2,120 2,001 2,075
Depreciation Expense
132 141 147 144 144 141 137 142 152 159 167
Impairment Charge
3.77 25 - 6.00 - 0.00 0.00 7.83 7.30 10 143
Restructuring Charge
- - 104 9.77 24 35 0.00 0.00 7.10 7.40 6.08
Other Special Charges / (Income)
- 6.65 -24 3.21 -0.04 0.11 0.94 0.24 0.00 0.00 2.66
Total Other Income / (Expense), net
-4.85 -8.72 -7.06 -15 -13 -121 -24 -4.50 -16 -19 -59
Interest Expense
27 35 37 36 39 39 48 29 37 37 77
Interest & Investment Income
22 21 23 28 28 27 24 24 21 18 17
Other Income / (Expense), net
- 5.64 6.56 -7.25 -2.25 -109 0.00 0.77 0.27 0.27 0.38
Income Tax Expense
104 86 -0.83 40 48 48 65 70 34 81 31
Basic Earnings per Share
$0.90 $0.79 $0.72 $0.74 $0.78 $0.72 $0.97 $1.08 $0.58 $1.18 $0.40
Weighted Average Basic Shares Outstanding
210.79M 208.51M 209.57M 211.02M 211.61M 211.78M 211.84M 211.90M 211.63M 211.02M 211.34M
Diluted Earnings per Share
$0.89 $0.78 $0.71 $0.74 $0.78 $0.72 $0.97 $1.07 $0.58 $1.17 $0.40
Weighted Average Diluted Shares Outstanding
213.36M 210.35M 210.44M 211.63M 211.97M 212.35M 213.03M 213.23M 213.36M 212.14M 212.11M
Weighted Average Basic & Diluted Shares Outstanding
210.20M 207.30M 208.50M 212.40M 211.58M 211.70M 211.54M 211.27M 210.57M 210.84M 211.55M
Cash Dividends to Common per Share
$0.57 $0.63 $0.67 $0.71 $0.75 $0.79 $0.83 $0.87 $0.91 $0.95 $0.98

Quarterly Income Statements for Flowers Foods

This table shows Flowers Foods' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 4/20/2024 7/13/2024 10/5/2024 12/28/2024 4/19/2025 7/12/2025 10/4/2025 1/3/2026 4/25/2026 7/18/2026
Net Income / (Loss) Attributable to Common Shareholders
36 73 67 65 43 53 58 40 -67 42 41
Consolidated Net Income / (Loss)
36 73 67 65 43 53 58 40 -67 42 41
Net Income / (Loss) Continuing Operations
36 73 67 65 43 53 58 40 -67 42 41
Total Pre-Tax Income
46 96 90 86 57 71 78 52 -87 60 54
Total Operating Income
50 102 95 90 61 85 93 67 -71 80 68
Total Gross Profit
541 780 612 592 543 776 607 588 598 776 578
Total Revenue
1,129 1,577 1,225 1,191 1,111 1,554 1,243 1,227 1,233 1,572 1,193
Operating Revenue
1,129 1,577 1,225 1,191 1,111 1,554 1,243 1,227 1,233 1,572 1,193
Total Cost of Revenue
588 797 613 598 568 778 636 639 634 795 615
Operating Cost of Revenue
588 797 613 598 568 778 636 639 634 795 615
Total Operating Expenses
492 678 516 502 482 691 513 521 670 696 510
Selling, General & Admin Expense
448 625 471 460 444 634 474 476 492 643 473
Depreciation Expense
37 48 37 37 37 49 40 40 38 52 39
Other Operating Expenses / (Income)
- - - - - - - - - - -1.96
Impairment Charge
6.26 4.00 1.38 4.48 0.45 7.40 0.00 0.00 136 0.00 0.00
Restructuring Charge
0.23 0.60 6.81 0.00 - 0.57 0.00 5.51 - 1.65 0.00
Other Special Charges / (Income)
- - - - - - 0.00 -0.09 - 0.12 0.09
Total Other Income / (Expense), net
-3.68 -5.45 -4.79 -4.66 -4.17 -14 -15 -14 -15 -20 -14
Interest Expense
8.21 11 8.98 8.69 8.16 20 19 18 20 25 18
Interest & Investment Income
4.33 5.69 4.07 3.91 3.84 5.63 3.84 3.77 4.14 5.03 4.07
Income Tax Expense
10 23 23 21 14 18 20 13 -20 18 14
Basic Earnings per Share
$0.17 $0.35 $0.32 $0.31 $0.20 $0.25 $0.28 $0.19 ($0.32) $0.20 $0.19
Weighted Average Basic Shares Outstanding
211.63M 211.08M 211.36M 210.82M 211.02M 211.19M 211.39M 211.42M 211.34M 211.87M 212.13M
Diluted Earnings per Share
$0.17 $0.34 $0.32 $0.31 $0.20 $0.25 $0.28 $0.19 ($0.32) $0.20 $0.19
Weighted Average Diluted Shares Outstanding
213.36M 212.11M 212.32M 211.98M 212.14M 212.14M 211.99M 212.11M 212.11M 212.58M 212.49M
Weighted Average Basic & Diluted Shares Outstanding
210.57M 211.14M 210.60M 210.60M 210.84M 211.14M 211.18M 211.18M 211.55M 211.99M 212.06M
Cash Dividends to Common per Share
$0.23 $0.23 $0.24 $0.24 $0.24 $0.24 $0.25 $0.25 $0.25 $0.25 $0.13

Annual Cash Flow Statements for Flowers Foods

This table details how cash moves in and out of Flowers Foods' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Net Change in Cash & Equivalents
6.86 -7.97 -1.28 20 -14 296 -122 -12 -143 -18 7.10
Net Cash From Operating Activities
336 357 297 296 367 454 345 361 349 413 446
Net Cash From Continuing Operating Activities
336 357 297 296 367 454 345 361 349 413 446
Net Income / (Loss) Continuing Operations
189 164 150 157 165 152 206 228 123 248 84
Consolidated Net Income / (Loss)
189 164 150 157 165 152 206 228 123 248 84
Depreciation Expense
132 141 147 144 144 141 137 142 152 159 167
Non-Cash Adjustments To Reconcile Net Income
31 56 58 32 41 163 29 40 52 56 189
Changes in Operating Assets and Liabilities, net
-17 -3.85 -57 -38 17 -2.24 -27 -50 22 -50 5.72
Net Cash From Investing Activities
-470 -77 -35 -302 -97 -74 -191 -151 -404 -173 -943
Net Cash From Continuing Investing Activities
-470 -77 -35 -302 -97 -74 -191 -151 -404 -173 -943
Purchase of Property, Plant & Equipment
-105 -111 -82 -103 -106 -101 -205 -177 -139 -181 -155
Acquisitions
-395 - - -200 0.00 0.00 -10 0.00 -275 0.00 -792
Purchase of Investments
- - - - - - 0.00 -9.00 -1.98 0.00 0.00
Sale of Property, Plant & Equipment
14 18 3.94 1.91 2.65 5.37 3.00 7.68 2.31 2.14 0.62
Sale and/or Maturity of Investments
23 22 25 27 29 32 32 39 28 26 24
Other Investing Activities, net
-6.83 -6.06 -24 -28 -23 -10 -11 -11 -18 -19 -20
Net Cash From Financing Activities
141 -288 -263 26 -284 -84 -275 -222 -88 -258 504
Net Cash From Continuing Financing Activities
141 -288 -263 26 -284 -84 -275 -222 -88 -258 504
Repayment of Debt
-818 -2,150 -751 -28 -720 -389 -585 -329 -743 -355 -287
Repurchase of Common Equity
-6.86 -126 -2.67 -2.49 -7.05 -0.78 -9.51 -35 -46 -23 -5.50
Payment of Dividends
-120 -131 -141 -150 -160 -167 -176 -187 -195 -203 -209
Issuance of Debt
1,067 2,092 612 206 609 485 498 330 898 324 1,006
Other Financing Activities, net
20 28 19 0.79 -5.94 -11 -1.75 -1.60 -1.82 -0.07 -0.08
Cash Interest Paid
24 27 34 33 36 36 53 28 35 36 60
Cash Income Taxes Paid
80 84 72 14 39 69 69 53 99 46 29

Quarterly Cash Flow Statements for Flowers Foods

This table details how cash moves in and out of Flowers Foods' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 4/20/2024 7/13/2024 10/5/2024 12/28/2024 4/19/2025 7/12/2025 10/4/2025 1/3/2026 4/25/2026 7/18/2026
Net Change in Cash & Equivalents
7.97 -6.71 -8.95 8.11 -9.97 2.34 3.71 5.69 -4.63 -0.58 41
Net Cash From Operating Activities
92 105 63 114 130 136 131 54 125 108 134
Net Cash From Continuing Operating Activities
92 105 63 114 130 136 131 54 125 108 134
Net Income / (Loss) Continuing Operations
36 73 67 65 43 53 58 40 -67 42 41
Consolidated Net Income / (Loss)
36 73 67 65 43 53 58 40 -67 42 41
Depreciation Expense
37 48 37 37 37 49 40 40 38 52 39
Non-Cash Adjustments To Reconcile Net Income
11 23 7.78 14 11 22 9.52 11 147 18 11
Changes in Operating Assets and Liabilities, net
8.27 -39 -48 -2.17 39 11 23 -36 7.03 -3.74 44
Net Cash From Investing Activities
-37 -36 -41 -36 -60 -836 -35 -24 -48 -20 -25
Net Cash From Continuing Investing Activities
-37 -36 -41 -36 -60 -836 -35 -24 -48 -20 -25
Purchase of Property, Plant & Equipment
-37 -39 -42 -39 -61 -26 -37 -25 -48 -21 -24
Sale and/or Maturity of Investments
2.86 7.93 5.76 5.97 5.85 -19 5.37 5.26 6.06 0.61 -2.77
Other Investing Activities, net
-3.22 -5.06 -5.54 -4.20 -4.30 0.28 -4.18 -4.35 -5.64 0.38 1.49
Net Cash From Financing Activities
-47 -76 -32 -69 -81 703 -92 -25 -82 -89 -67
Net Cash From Continuing Financing Activities
-47 -76 -32 -69 -81 703 -92 -25 -82 -89 -67
Repayment of Debt
-76 -133 -76 -77 -69 -83 -62 -72 -70 -81 -42
Repurchase of Common Equity
-15 -8.88 -14 - - -5.50 - - - -3.79 -0.04
Payment of Dividends
-48 -51 -51 -51 -51 -52 -52 -52 -52 -54 -27
Issuance of Debt
93 118 109 58 39 844 23 99 40 51 1.10

Annual Balance Sheets for Flowers Foods

This table presents Flowers Foods' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Total Assets
2,844 2,761 2,660 2,846 3,178 3,323 3,253 3,313 3,427 3,400 4,184
Total Current Assets
500 477 507 544 554 838 746 805 688 656 729
Cash & Equivalents
14 6.41 5.13 25 11 307 186 165 23 5.01 12
Note & Lease Receivable
270 272 280 287 286 300 305 349 328 335 353
Inventories, net
168 170 172 188 195 193 203 242 271 263 299
Other Current Assets
48 28 50 43 63 37 52 48 66 54 65
Plant, Property, & Equipment, net
805 781 732 744 718 699 799 849 963 964 953
Plant, Property & Equipment, gross
1,881 1,891 1,907 1,982 2,003 2,034 4,385 2,297 2,501 2,575 2,625
Accumulated Depreciation
1,076 1,110 1,175 1,238 1,285 1,334 1,394 1,447 1,538 1,611 1,672
Total Noncurrent Assets
1,539 1,503 1,421 1,558 1,906 1,785 1,708 1,659 1,776 1,780 2,502
Noncurrent Note & Lease Receivables
154 155 188 204 221 182 158 139 124 108 109
Goodwill
465 466 465 545 545 545 545 545 678 680 1,048
Intangible Assets
875 836 742 795 750 715 695 664 658 499 502
Other Noncurrent Operating Assets
7.88 9.76 10 6.93 389 343 310 310 317 492 843
Total Liabilities & Shareholders' Equity
2,844 2,761 2,660 2,846 3,178 3,323 3,253 3,313 3,427 3,400 4,184
Total Liabilities
1,601 1,551 1,409 1,587 1,914 1,950 1,842 1,870 2,075 1,990 2,880
Total Current Liabilities
404 341 394 400 528 504 520 564 659 549 976
Short-Term Debt
75 11 12 11 3.73 0.00 0.00 - - 0.00 400
Accounts Payable
172 173 181 242 233 226 269 343 319 261 313
Accrued Expenses
157 156 200 146 201 226 203 175 293 219 190
Other Current Liabilities
- - - - 61 52 48 46 48 69 74
Total Noncurrent Liabilities
1,197 1,210 1,015 1,187 1,386 1,446 1,322 1,305 1,416 1,442 1,904
Long-Term Debt
930 947 820 975 863 960 891 892 1,048 1,022 1,356
Capital Lease Obligations
- - - 16 344 294 253 237 237 254 251
Noncurrent Deferred & Payable Income Tax Liabilities
146 146 83 103 121 128 134 135 91 124 247
Noncurrent Employee Benefit Liabilities
77 70 60 39 14 10 7.25 5.81 5.80 5.51 8.60
Other Noncurrent Operating Liabilities
44 48 52 54 44 54 38 36 34 36 42
Commitments & Contingencies
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,243 1,210 1,251 1,258 1,263 1,373 1,411 1,443 1,352 1,410 1,303
Total Preferred & Common Equity
1,243 1,210 1,251 1,258 1,263 1,373 1,411 1,443 1,352 1,410 1,303
Preferred Stock
- - - 0.00 0.00 0.00 - 0.00 0.00 0.00 0.00
Total Common Equity
1,243 1,210 1,251 1,258 1,263 1,373 1,411 1,443 1,352 1,410 1,303
Common Stock
637 645 651 654 649 660 679 690 700 712 730
Retained Earnings
878 911 920 945 947 932 962 1,004 932 978 852
Treasury Stock
-175 -262 -235 -232 -226 -225 -232 -253 -281 -286 -278
Accumulated Other Comprehensive Income / (Loss)
-97 -83 -85 -109 -106 6.42 2.59 1.47 0.62 6.83 -1.13

Quarterly Balance Sheets for Flowers Foods

This table presents Flowers Foods' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2023 Q2 2023 Q3 2023 Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026
Period end date 4/22/2023 7/15/2023 10/7/2023 4/20/2024 7/13/2024 10/5/2024 4/19/2025 7/12/2025 10/4/2025 4/25/2026 7/18/2026
Total Assets
3,482 3,506 3,435 3,429 3,428 3,430 4,327 4,345 4,350 4,181 4,186
Total Current Assets
716 749 715 688 703 708 715 741 752 762 786
Cash & Equivalents
28 12 15 16 6.87 15 7.34 11 17 12 53
Note & Lease Receivable
372 429 365 359 390 387 361 357 369 375 372
Inventories, net
265 257 266 265 260 259 299 304 299 301 310
Other Current Assets
52 52 69 49 46 46 48 68 67 74 52
Plant, Property, & Equipment, net
959 962 962 959 955 948 948 944 937 932 927
Plant, Property & Equipment, gross
2,438 2,467 2,490 2,532 2,554 2,548 2,574 2,583 2,600 2,643 2,663
Accumulated Depreciation
1,479 1,505 1,528 1,573 1,599 1,600 1,626 1,639 1,663 1,711 1,736
Total Noncurrent Assets
1,807 1,795 1,758 1,782 1,770 1,775 2,664 2,660 2,660 2,487 2,473
Noncurrent Note & Lease Receivables
135 132 115 119 114 113 107 108 108 108 108
Goodwill
676 678 678 680 680 680 1,067 1,048 1,048 1,047 1,047
Intangible Assets
682 675 665 648 641 634 1,123 657 1,130 974 965
Other Noncurrent Operating Assets
313 310 301 335 336 349 367 848 375 358 352
Total Liabilities & Shareholders' Equity
3,482 3,506 3,435 3,429 3,428 3,430 4,327 4,345 4,350 4,181 4,186
Total Liabilities
2,020 2,036 2,060 2,053 2,044 2,023 2,911 2,917 2,929 2,878 2,862
Total Current Liabilities
542 555 670 622 589 569 569 589 958 988 1,018
Short-Term Debt
- - - - - - - - 399 400 400
Accounts Payable
343 328 329 304 299 287 330 328 319 330 331
Accrued Expenses
148 177 292 261 230 217 166 188 165 192 212
Other Current Liabilities
51 51 50 58 60 65 73 73 75 67 75
Total Noncurrent Liabilities
1,478 1,480 1,390 1,431 1,454 1,454 2,343 2,328 1,972 1,890 1,844
Long-Term Debt
1,063 1,075 1,038 1,044 1,069 1,054 1,790 1,749 1,380 1,324 1,286
Capital Lease Obligations
237 231 222 247 244 251 260 255 263 252 242
Noncurrent Deferred & Payable Income Tax Liabilities
136 134 91 98 100 108 234 265 270 267 270
Noncurrent Employee Benefit Liabilities
5.80 5.61 5.50 5.70 5.57 5.32 5.24 5.21 5.25 8.72 8.82
Other Noncurrent Operating Liabilities
36 35 34 36 35 36 54 53 54 38 37
Commitments & Contingencies
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests
1,462 1,470 1,375 1,376 1,384 1,407 1,416 1,428 1,420 1,302 1,324
Total Preferred & Common Equity
1,462 1,470 1,375 1,376 1,384 1,407 1,416 1,428 1,420 1,302 1,324
Preferred Stock
- 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity
1,462 1,470 1,375 1,376 1,384 1,407 1,416 1,428 1,420 1,302 1,324
Common Stock
684 688 694 694 699 705 711 717 724 724 730
Retained Earnings
1,026 1,041 945 954 971 985 978 984 971 840 854
Treasury Stock
-248 -262 -266 -273 -286 -286 -279 -278 -278 -263 -262
Accumulated Other Comprehensive Income / (Loss)
-0.69 2.66 1.33 0.53 0.94 2.24 5.16 4.21 3.08 1.75 1.70

Annual Metrics And Ratios for Flowers Foods

This table displays calculated financial ratios and metrics derived from Flowers Foods' official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 1/2/2016 12/31/2016 12/30/2017 12/29/2018 12/28/2019 1/2/2021 1/1/2022 12/31/2022 12/30/2023 12/28/2024 1/3/2026
Growth Metrics
- - - - - - - - - - -
Revenue Growth
0.79% 3.93% -0.16% 0.79% 4.36% 6.40% -1.30% 10.97% 5.93% 0.25% 3.00%
EBITDA Growth
6.36% -5.88% -23.50% 12.78% 5.21% -3.60% 21.82% 3.35% -27.16% 56.31% -32.69%
EBIT Growth
8.16% -11.41% -38.27% 25.89% 8.82% -4.65% 38.59% 3.07% -43.04% 101.32% -49.98%
NOPAT Growth
6.52% -11.87% -7.24% 7.66% 3.33% 39.50% -7.95% 3.23% -41.43% 93.46% -51.76%
Net Income Growth
7.65% -13.43% -8.34% 4.69% 4.69% -7.43% 35.37% 10.77% -45.96% 101.04% -66.22%
EPS Growth
8.54% -12.36% -8.97% 4.23% 5.41% -7.69% 34.72% 10.31% -45.79% 101.72% -65.81%
Operating Cash Flow Growth
6.50% 6.22% -16.60% -0.50% 24.02% 23.85% -24.17% 4.72% -3.20% 18.12% 8.13%
Free Cash Flow Firm Growth
-159.51% 246.54% -9.20% -98.25% -1,655.93% 748.83% -54.64% 10.15% -136.94% 374.20% -350.20%
Invested Capital Growth
19.42% -3.29% -2.94% 8.02% 10.53% -5.80% 2.12% 1.63% 8.61% 2.56% 23.00%
Revenue Q/Q Growth
-0.50% 0.26% 0.13% 0.18% 0.91% 2.46% -0.90% 2.11% 0.92% -0.35% 2.37%
EBITDA Q/Q Growth
2.95% -7.02% 11.03% -4.66% -6.17% 25.93% -5.23% 2.75% -2.88% 2.32% -27.62%
EBIT Q/Q Growth
3.52% -10.32% 23.12% -7.57% -10.02% 53.80% -7.62% 3.79% -7.45% 3.48% -43.10%
NOPAT Q/Q Growth
2.41% -11.15% 72.35% -23.84% -9.90% 26.85% -7.13% 3.61% -6.83% 3.09% -44.84%
Net Income Q/Q Growth
2.29% -10.50% 77.39% -26.85% -10.17% 54.30% -7.41% 4.23% -9.48% 3.09% -56.80%
EPS Q/Q Growth
1.14% -9.30% 73.17% -26.73% -9.30% 53.19% -7.62% 3.88% -9.38% 2.63% -56.52%
Operating Cash Flow Q/Q Growth
-10.60% 4.58% 0.89% -3.12% 7.32% 0.26% -14.96% 12.45% 6.94% 10.22% -1.09%
Free Cash Flow Firm Q/Q Growth
-770.51% 55.65% 16.33% -98.02% 77.69% 10.04% -88.21% 118.23% 16.30% 10.10% 5.69%
Invested Capital Q/Q Growth
5.51% 0.33% 2.09% 8.75% -1.89% -1.33% 114.46% 0.77% -0.21% -0.58% -4.30%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
48.04% 48.39% 48.75% 47.70% 47.73% 49.95% 49.77% 47.94% 48.30% 49.50% 48.87%
EBITDA Margin
11.38% 10.31% 7.90% 8.84% 8.91% 8.07% 9.96% 9.28% 6.38% 9.95% 6.50%
Operating Margin
7.88% 6.58% 3.99% 5.37% 5.47% 7.33% 6.81% 6.31% 3.40% 6.82% 3.31%
EBIT Margin
7.88% 6.72% 4.16% 5.19% 5.41% 4.85% 6.81% 6.33% 3.40% 6.83% 3.32%
Profit (Net Income) Margin
5.01% 4.17% 3.83% 3.98% 3.99% 3.47% 4.76% 4.75% 2.42% 4.86% 1.59%
Tax Burden Percent
64.56% 65.63% 100.55% 79.71% 77.58% 75.89% 76.15% 76.46% 78.56% 75.43% 72.85%
Interest Burden Percent
98.37% 94.56% 91.64% 96.13% 95.03% 94.32% 91.81% 98.26% 90.74% 94.37% 65.99%
Effective Tax Rate
35.44% 34.37% -0.55% 20.29% 22.42% 24.11% 23.85% 23.54% 21.44% 24.57% 27.15%
Return on Invested Capital (ROIC)
9.53% 7.84% 7.51% 7.89% 7.46% 10.20% 9.58% 9.71% 5.41% 9.92% 4.24%
ROIC Less NNEP Spread (ROIC-NNEP)
9.15% 7.23% 6.69% 6.53% 6.50% 1.66% 7.65% 9.35% 4.30% 8.77% 1.61%
Return on Net Nonoperating Assets (RNNOA)
6.46% 5.51% 4.69% 4.64% 5.59% 1.35% 5.23% 6.29% 3.42% 8.05% 1.94%
Return on Equity (ROE)
15.99% 13.35% 12.20% 12.53% 13.05% 11.55% 14.81% 16.00% 8.83% 17.97% 6.18%
Cash Return on Invested Capital (CROIC)
-8.18% 11.19% 10.49% 0.18% -2.54% 16.18% 7.49% 8.10% -2.84% 7.39% -16.39%
Operating Return on Assets (OROA)
11.34% 9.42% 6.01% 7.45% 7.41% 6.55% 8.97% 9.26% 5.14% 10.21% 4.60%
Return on Assets (ROA)
7.20% 5.84% 5.54% 5.71% 5.46% 4.69% 6.27% 6.96% 3.66% 7.27% 2.21%
Return on Common Equity (ROCE)
15.99% 13.35% 12.20% 12.53% 13.05% 11.55% 14.81% 16.00% 8.83% 17.97% 6.18%
Return on Equity Simple (ROE_SIMPLE)
15.22% 13.53% 12.00% 12.49% 13.02% 11.09% 14.61% 15.82% 9.13% 17.60% 0.00%
Net Operating Profit after Tax (NOPAT)
192 169 157 169 175 244 225 232 136 263 127
NOPAT Margin
5.09% 4.32% 4.01% 4.28% 4.24% 5.56% 5.19% 4.82% 2.67% 5.15% 2.41%
Net Nonoperating Expense Percent (NNEP)
0.37% 0.61% 0.82% 1.36% 0.95% 8.54% 1.93% 0.36% 1.11% 1.15% 2.63%
Return On Investment Capital (ROIC_SIMPLE)
- - - - - - - 9.01% 5.15% 9.78% 3.83%
Cost of Revenue to Revenue
51.96% 51.61% 51.25% 52.30% 52.27% 50.05% 50.23% 52.06% 51.70% 50.50% 51.13%
SG&A Expenses to Revenue
36.56% 37.42% 38.51% 38.14% 38.19% 38.59% 39.71% 38.51% 41.64% 39.21% 39.48%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
40.16% 41.81% 44.76% 42.33% 42.26% 42.62% 42.96% 41.63% 44.90% 42.68% 45.56%
Earnings before Interest and Taxes (EBIT)
298 264 163 205 223 213 295 304 173 349 174
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
430 405 310 349 367 354 431 446 325 508 342
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
2.71 2.63 2.58 2.53 3.10 3.08 3.76 3.88 3.37 3.06 1.75
Price to Tangible Book Value (P/TBV)
0.00 0.00 74.12 0.00 0.00 37.47 31.10 23.98 280.70 41.51 0.00
Price to Revenue (P/Rev)
0.89 0.81 0.82 0.80 0.95 0.96 1.23 1.17 0.90 0.84 0.43
Price to Earnings (P/E)
17.81 19.44 21.46 20.23 23.84 27.75 25.73 24.54 36.95 17.37 27.18
Dividend Yield
3.57% 4.08% 4.36% 4.71% 4.04% 3.95% 3.31% 3.28% 4.21% 4.64% 9.11%
Earnings Yield
5.61% 5.14% 4.66% 4.94% 4.19% 3.60% 3.89% 4.08% 2.71% 5.76% 3.68%
Enterprise Value to Invested Capital (EV/IC)
1.98 1.95 1.96 1.87 2.08 2.23 2.64 2.73 2.23 2.08 1.30
Enterprise Value to Revenue (EV/Rev)
1.15 1.05 1.03 1.05 1.24 1.18 1.45 1.37 1.14 1.09 0.81
Enterprise Value to EBITDA (EV/EBITDA)
10.14 10.22 13.07 11.90 13.94 14.61 14.51 14.73 17.92 10.99 12.50
Enterprise Value to EBIT (EV/EBIT)
14.64 15.67 24.85 20.26 22.95 24.31 21.24 21.61 33.63 16.01 24.51
Enterprise Value to NOPAT (EV/NOPAT)
22.67 24.40 25.75 24.55 29.28 21.21 27.89 28.33 42.87 21.25 33.71
Enterprise Value to Operating Cash Flow (EV/OCF)
12.99 11.60 13.61 14.05 13.96 11.38 18.17 18.20 16.67 13.53 9.58
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 17.10 18.43 1,084.35 0.00 13.37 35.69 33.98 0.00 28.51 0.00
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.81 0.79 0.67 0.80 0.96 0.91 0.81 0.78 0.95 0.91 1.54
Long-Term Debt to Equity
0.75 0.78 0.66 0.79 0.95 0.91 0.81 0.78 0.95 0.91 1.23
Financial Leverage
0.71 0.76 0.70 0.71 0.86 0.81 0.68 0.67 0.80 0.92 1.20
Leverage Ratio
2.22 2.28 2.20 2.19 2.39 2.47 2.36 2.30 2.41 2.47 2.79
Compound Leverage Factor
2.18 2.16 2.02 2.11 2.27 2.33 2.17 2.26 2.19 2.33 1.84
Debt to Total Capital
44.70% 44.19% 39.96% 44.32% 48.92% 47.73% 44.75% 43.89% 48.73% 47.51% 60.62%
Short-Term Debt to Total Capital
3.32% 0.53% 0.58% 0.48% 0.15% 0.00% 0.00% 0.00% 0.00% 0.00% 12.07%
Long-Term Debt to Total Capital
41.38% 43.66% 39.37% 43.84% 48.77% 47.73% 44.75% 43.89% 48.73% 47.51% 48.55%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
55.30% 55.81% 60.04% 55.68% 51.08% 52.27% 55.25% 56.11% 51.27% 52.49% 39.38%
Debt to EBITDA
2.34 2.37 2.69 2.87 3.29 3.54 2.65 2.53 3.96 2.51 5.87
Net Debt to EBITDA
2.30 2.35 2.67 2.80 3.26 2.67 2.22 2.16 3.89 2.50 5.84
Long-Term Debt to EBITDA
2.16 2.34 2.65 2.84 3.28 3.54 2.65 2.53 3.96 2.51 4.70
Debt to NOPAT
5.22 5.65 5.29 5.92 6.92 5.14 5.09 4.87 9.46 4.86 15.83
Net Debt to NOPAT
5.15 5.62 5.26 5.77 6.86 3.88 4.26 4.16 9.30 4.84 15.74
Long-Term Debt to NOPAT
4.84 5.59 5.22 5.85 6.90 5.14 5.09 4.87 9.46 4.86 12.68
Altman Z-Score
3.41 3.49 3.58 3.35 3.19 3.35 3.86 4.06 3.36 3.58 2.08
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.24 1.40 1.29 1.36 1.05 1.66 1.44 1.43 1.04 1.20 0.75
Quick Ratio
0.70 0.82 0.72 0.78 0.56 1.21 0.94 0.91 0.53 0.62 0.37
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-165 242 220 3.83 -60 387 175 193 -71 196 -490
Operating Cash Flow to CapEx
369.74% 383.68% 382.46% 294.02% 353.72% 475.01% 170.39% 212.85% 255.43% 230.44% 288.21%
Free Cash Flow to Firm to Interest Expense
-6.16 6.93 6.01 0.11 -1.54 9.97 3.68 6.68 -1.95 5.27 -6.39
Operating Cash Flow to Interest Expense
12.52 10.22 8.13 8.29 9.45 11.72 7.23 12.48 9.54 11.11 5.82
Operating Cash Flow Less CapEx to Interest Expense
9.13 7.55 6.01 5.47 6.78 9.25 2.99 6.62 5.81 6.29 3.80
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.44 1.40 1.45 1.44 1.37 1.35 1.32 1.46 1.51 1.50 1.39
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
12.44 11.96 11.73 11.48 11.28 11.32 10.96 11.23 10.26 9.66 9.57
Fixed Asset Turnover
4.69 4.95 5.18 5.36 5.64 6.19 5.78 5.83 5.62 5.30 5.48
Accounts Payable Turnover
12.48 11.75 11.34 9.76 9.07 9.57 8.80 8.18 7.95 8.90 9.37
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
29.34 30.51 31.13 31.79 32.36 32.23 33.29 32.52 35.58 37.78 38.16
Days Payable Outstanding (DPO)
29.24 31.07 32.19 37.39 40.22 38.14 41.48 44.63 45.90 41.02 38.94
Cash Conversion Cycle (CCC)
0.10 -0.56 -1.06 -5.60 -7.86 -5.91 -8.19 -12.12 -10.32 -3.24 -0.78
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,197 2,125 2,062 2,228 2,462 2,319 2,369 2,407 2,614 2,681 3,298
Invested Capital Turnover
1.87 1.82 1.87 1.84 1.76 1.84 1.85 2.01 2.03 1.93 1.76
Increase / (Decrease) in Invested Capital
357 -72 -62 165 235 -143 49 39 207 67 617
Enterprise Value (EV)
4,360 4,136 4,048 4,156 5,121 5,174 6,263 6,568 5,822 5,582 4,273
Market Capitalization
3,370 3,184 3,221 3,180 3,922 4,227 5,306 5,604 4,560 4,311 2,279
Book Value per Share
$5.86 $5.83 $5.97 $5.97 $5.97 $6.49 $6.68 $6.84 $6.40 $6.70 $6.17
Tangible Book Value per Share
($0.46) ($0.44) $0.21 ($0.39) ($0.15) $0.53 $0.81 $1.11 $0.08 $0.49 ($1.17)
Total Capital
2,248 2,168 2,083 2,260 2,473 2,627 2,554 2,572 2,637 2,686 3,310
Total Debt
1,005 958 832 1,002 1,210 1,254 1,143 1,129 1,285 1,276 2,006
Total Long-Term Debt
930 947 820 991 1,206 1,254 1,143 1,129 1,285 1,276 1,607
Net Debt
990 952 827 976 1,199 946 957 964 1,263 1,271 1,994
Capital Expenditures (CapEx)
91 93 78 101 104 96 202 170 137 179 155
Debt-free, Cash-free Net Working Capital (DFCFNWC)
157 141 120 129 18 27 40 75 6.03 103 140
Debt-free Net Working Capital (DFNWC)
171 148 125 154 30 334 226 241 29 108 153
Net Working Capital (NWC)
97 136 113 143 26 334 226 241 29 108 -247
Net Nonoperating Expense (NNE)
3.13 5.72 7.10 12 10 92 18 3.44 12 15 43
Net Nonoperating Obligations (NNO)
954 915 812 970 1,199 946 957 964 1,263 1,271 1,994
Total Depreciation and Amortization (D&A)
132 141 147 144 144 141 137 142 152 159 167
Debt-free, Cash-free Net Working Capital to Revenue
4.15% 3.60% 3.07% 3.26% 0.45% 0.61% 0.93% 1.57% 0.12% 2.01% 2.67%
Debt-free Net Working Capital to Revenue
4.53% 3.76% 3.20% 3.90% 0.72% 7.61% 5.22% 5.00% 0.56% 2.11% 2.90%
Net Working Capital to Revenue
2.56% 3.47% 2.89% 3.63% 0.63% 7.61% 5.22% 5.00% 0.56% 2.11% -4.70%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.00 $0.79 $0.72 $0.74 $0.78 $0.72 $0.97 $1.08 $0.58 $1.18 $0.40
Adjusted Weighted Average Basic Shares Outstanding
210.79M 208.51M 209.57M 211.02M 211.61M 211.78M 211.84M 211.90M 211.63M 211.02M 211.34M
Adjusted Diluted Earnings per Share
$0.00 $0.78 $0.71 $0.74 $0.78 $0.72 $0.97 $1.07 $0.58 $1.17 $0.40
Adjusted Weighted Average Diluted Shares Outstanding
213.36M 210.35M 210.44M 211.63M 211.97M 212.35M 213.03M 213.23M 213.36M 212.14M 212.11M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
212.30M 208.90M 210.61M 210.90M 211.58M 211.70M 211.54M 211.27M 210.57M 210.84M 211.55M
Normalized Net Operating Profit after Tax (NOPAT)
195 190 165 184 193 271 225 238 147 276 238
Normalized NOPAT Margin
5.15% 4.84% 4.22% 4.67% 4.68% 6.18% 5.20% 4.95% 2.89% 5.41% 4.52%
Pre Tax Income Margin
7.76% 6.35% 3.81% 4.99% 5.14% 4.57% 6.25% 6.22% 3.09% 6.45% 2.19%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
11.11 7.56 4.46 5.75 5.75 5.49 6.19 10.51 4.73 9.39 2.27
NOPAT to Interest Expense
7.17 4.86 4.30 4.74 4.50 6.29 4.71 8.02 3.71 7.08 1.65
EBIT Less CapEx to Interest Expense
7.72 4.90 2.33 2.93 3.07 3.02 1.94 4.65 0.99 4.56 0.25
NOPAT Less CapEx to Interest Expense
3.79 2.19 2.17 1.92 1.83 3.82 0.47 2.15 -0.03 2.25 -0.37
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
63.66% 80.03% 93.91% 95.58% 97.23% 109.82% 85.31% 81.66% 158.18% 81.83% 249.69%
Augmented Payout Ratio
67.29% 157.15% 95.69% 97.16% 101.52% 110.33% 89.92% 96.80% 195.29% 90.98% 256.25%

Quarterly Metrics And Ratios for Flowers Foods

This table displays calculated financial ratios and metrics derived from Flowers Foods' official financial filings.

Metric Q4 2023 Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026
Period end date 12/30/2023 4/20/2024 7/13/2024 10/5/2024 12/28/2024 4/19/2025 7/12/2025 10/4/2025 1/3/2026 4/25/2026 7/18/2026
DEI Shares Outstanding
- - - - - - - - - 211,554,322.00 211,993,230.00
DEI Adjusted Shares Outstanding
- - - - - - - - - 211,554,322.00 211,993,230.00
DEI Earnings Per Adjusted Shares Outstanding
- - - - - - - - - 0.20 0.19
Growth Metrics
- - - - - - - - - - -
Revenue Growth
4.28% 2.76% -0.25% -0.73% -1.59% -1.43% 1.46% 3.02% 10.96% 1.12% -4.02%
EBITDA Growth
-10.22% 8.93% 6.83% 646.01% 12.95% -10.29% 0.82% -16.64% -133.27% -2.17% -19.96%
EBIT Growth
-22.15% 8.30% 7.44% 252.15% 22.96% -16.18% -2.01% -26.34% -216.09% -6.38% -27.13%
NOPAT Growth
-20.68% 4.73% 5.36% 264.94% 20.33% -17.91% -1.46% -26.41% -207.02% -11.81% -26.52%
Net Income Growth
-26.59% 3.30% 5.03% 239.06% 20.87% -27.44% -12.85% -39.16% -255.54% -20.65% -30.34%
EPS Growth
-26.09% 3.03% 6.67% 240.91% 17.65% -26.47% -12.50% -38.71% -260.00% -20.00% -32.14%
Operating Cash Flow Growth
32.70% 81.44% -10.83% -11.26% 41.57% 28.99% 106.77% -52.29% -3.77% -20.48% 2.19%
Free Cash Flow Firm Growth
-1,755.74% 160.96% 151.88% 96.89% 87.88% -564.22% -559.51% -8,140.49% -3,161.43% 133.26% 141.32%
Invested Capital Growth
8.61% -3.04% -2.66% 2.94% 2.56% 30.45% 27.16% 27.78% 23.00% -5.54% -6.49%
Revenue Q/Q Growth
-5.86% 39.66% -22.31% -2.81% -6.67% 39.88% -20.04% -1.31% 0.51% 27.47% -24.09%
EBITDA Q/Q Growth
471.82% 72.34% -11.85% -3.34% -23.08% 37.03% -0.95% -20.15% -130.66% 503.44% -18.92%
EBIT Q/Q Growth
184.07% 103.52% -6.24% -5.16% -32.06% 38.95% 9.57% -28.79% -206.86% 212.28% -14.64%
NOPAT Q/Q Growth
193.00% 99.78% -8.65% -2.82% -32.15% 36.30% 9.65% -27.43% -198.68% 212.32% -8.65%
Net Income Q/Q Growth
176.35% 104.74% -8.32% -2.96% -33.64% 22.90% 10.13% -32.26% -269.66% 162.70% -3.33%
EPS Q/Q Growth
177.27% 100.00% -5.88% -3.13% -35.48% 25.00% 12.00% -32.14% -268.42% 162.50% -5.00%
Operating Cash Flow Q/Q Growth
-28.33% 14.25% -39.83% 80.09% 14.34% 4.10% -3.54% -58.45% 130.65% -13.98% 23.95%
Free Cash Flow Firm Q/Q Growth
38.17% 195.07% -10.21% -105.89% -140.94% -3,541.31% 11.12% -5.67% 4.64% 137.14% 10.41%
Invested Capital Q/Q Growth
-0.21% 1.41% 1.48% 0.24% -0.58% 28.99% -1.08% 0.73% -4.30% -0.94% -2.08%
Profitability Metrics
- - - - - - - - - - -
Gross Margin
47.94% 49.44% 49.93% 49.75% 48.84% 49.92% 48.82% 47.93% 48.54% 49.39% 48.45%
EBITDA Margin
7.70% 9.50% 10.78% 10.72% 8.84% 8.66% 10.72% 8.67% -2.65% 8.37% 8.95%
Operating Margin
4.42% 6.44% 7.77% 7.57% 5.52% 5.48% 7.52% 5.42% -5.77% 5.08% 5.71%
EBIT Margin
4.42% 6.44% 7.77% 7.58% 5.52% 5.49% 7.52% 5.42% -5.77% 5.08% 5.71%
Profit (Net Income) Margin
3.16% 4.63% 5.47% 5.46% 3.88% 3.41% 4.70% 3.22% -5.44% 2.68% 3.41%
Tax Burden Percent
77.43% 76.01% 74.06% 75.99% 75.78% 74.43% 74.38% 75.81% 77.32% 70.02% 74.94%
Interest Burden Percent
92.34% 94.63% 94.97% 94.71% 92.75% 83.52% 84.00% 78.40% 122.04% 75.25% 79.63%
Effective Tax Rate
22.57% 23.99% 25.94% 24.01% 24.22% 25.57% 25.62% 24.19% 0.00% 29.98% 25.06%
Return on Invested Capital (ROIC)
6.94% 9.33% 10.83% 11.09% 8.07% 6.78% 9.33% 6.87% -7.10% 5.58% 6.75%
ROIC Less NNEP Spread (ROIC-NNEP)
6.67% 9.01% 10.56% 10.81% 7.80% 6.16% 8.65% 6.22% -8.16% 4.89% 6.22%
Return on Net Nonoperating Assets (RNNOA)
5.32% 8.09% 9.61% 9.85% 7.15% 7.32% 10.15% 7.29% -9.82% 7.20% 8.74%
Return on Equity (ROE)
12.25% 17.42% 20.44% 20.94% 15.22% 14.10% 19.48% 14.16% -16.91% 12.78% 15.50%
Cash Return on Invested Capital (CROIC)
-2.84% 8.25% 7.92% 6.69% 7.39% -18.28% -15.80% -16.91% -16.39% 9.22% 9.71%
Operating Return on Assets (OROA)
6.68% 9.57% 11.50% 11.32% 8.26% 7.19% 9.86% 7.16% -7.99% 6.30% 6.99%
Return on Assets (ROA)
4.77% 6.88% 8.09% 8.14% 5.80% 4.47% 6.16% 4.25% -7.54% 3.32% 4.17%
Return on Common Equity (ROCE)
12.25% 17.42% 20.44% 20.94% 15.22% 14.10% 19.48% 14.16% -16.91% 12.78% 15.50%
Return on Equity Simple (ROE_SIMPLE)
0.00% 9.14% 9.31% 17.11% 0.00% 16.11% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)
39 77 71 69 46 63 69 50 -50 56 51
NOPAT Margin
3.42% 4.90% 5.76% 5.76% 4.18% 4.08% 5.59% 4.11% -4.04% 3.56% 4.28%
Net Nonoperating Expense Percent (NNEP)
0.27% 0.33% 0.27% 0.28% 0.27% 0.63% 0.67% 0.66% 1.06% 0.69% 0.54%
Return On Investment Capital (ROIC_SIMPLE)
1.47% - - - 1.73% 1.83% 2.02% 1.46% -1.50% 1.70% 1.57%
Cost of Revenue to Revenue
52.06% 50.56% 50.07% 50.25% 51.16% 50.08% 51.18% 52.07% 51.46% 50.61% 51.55%
SG&A Expenses to Revenue
39.67% 39.65% 38.48% 38.67% 39.96% 40.76% 38.10% 38.80% 39.94% 40.91% 39.67%
R&D to Revenue
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue
43.54% 42.99% 42.15% 42.18% 43.34% 44.44% 41.30% 42.50% 54.32% 44.32% 42.74%
Earnings before Interest and Taxes (EBIT)
50 102 95 90 61 85 93 67 -71 80 68
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)
87 150 132 128 98 135 133 106 -33 132 107
Valuation Ratios
- - - - - - - - - - -
Price to Book Value (P/BV)
3.37 3.73 3.27 3.35 3.06 2.72 2.33 1.96 1.75 1.43 1.36
Price to Tangible Book Value (P/TBV)
280.70 107.09 71.04 50.68 41.51 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)
0.90 1.00 0.88 0.92 0.84 0.76 0.65 0.54 0.43 0.35 0.34
Price to Earnings (P/E)
36.95 40.84 35.12 19.60 17.37 16.88 15.17 14.32 27.18 25.54 32.62
Dividend Yield
4.21% 3.78% 4.34% 4.20% 4.64% 5.26% 6.14% 7.41% 9.11% 11.25% 10.22%
Earnings Yield
2.71% 2.45% 2.85% 5.10% 5.76% 5.92% 6.59% 6.98% 3.68% 3.91% 3.07%
Enterprise Value to Invested Capital (EV/IC)
2.23 2.42 2.17 2.23 2.08 1.70 1.56 1.39 1.30 1.17 1.15
Enterprise Value to Revenue (EV/Rev)
1.14 1.25 1.14 1.17 1.09 1.16 1.04 0.94 0.81 0.73 0.70
Enterprise Value to EBITDA (EV/EBITDA)
17.92 19.03 16.90 12.11 10.99 11.97 10.79 10.18 12.50 11.30 11.78
Enterprise Value to EBIT (EV/EBIT)
33.63 35.49 31.15 17.84 16.01 17.74 16.13 15.68 24.51 22.68 25.63
Enterprise Value to NOPAT (EV/NOPAT)
42.87 46.07 40.90 23.57 21.25 23.67 21.46 20.91 33.71 32.35 37.04
Enterprise Value to Operating Cash Flow (EV/OCF)
16.67 16.17 15.01 16.05 13.53 13.30 10.42 10.65 9.58 9.14 8.72
Enterprise Value to Free Cash Flow (EV/FCFF)
0.00 28.85 27.01 33.78 28.51 0.00 0.00 0.00 0.00 12.35 11.43
Leverage & Solvency
- - - - - - - - - - -
Debt to Equity
0.95 0.94 0.95 0.93 0.91 1.45 1.40 1.44 1.54 1.52 1.46
Long-Term Debt to Equity
0.95 0.94 0.95 0.93 0.91 1.45 1.40 1.16 1.23 1.21 1.15
Financial Leverage
0.80 0.90 0.91 0.91 0.92 1.19 1.17 1.17 1.20 1.47 1.41
Leverage Ratio
2.41 2.44 2.43 2.47 2.47 2.78 2.76 2.75 2.79 3.13 3.10
Compound Leverage Factor
2.23 2.30 2.31 2.34 2.29 2.32 2.32 2.16 3.41 2.36 2.47
Debt to Total Capital
48.73% 48.41% 48.67% 48.13% 47.51% 59.15% 58.40% 58.98% 60.62% 60.27% 59.30%
Short-Term Debt to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.54% 12.07% 12.19% 12.30%
Long-Term Debt to Total Capital
48.73% 48.41% 48.67% 48.13% 47.51% 59.15% 58.40% 47.44% 48.55% 48.08% 47.00%
Preferred Equity to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital
51.27% 51.59% 51.33% 51.87% 52.49% 40.85% 41.60% 41.02% 39.38% 39.73% 40.70%
Debt to EBITDA
3.96 3.83 3.80 2.63 2.51 4.16 4.06 4.33 5.87 5.84 6.18
Net Debt to EBITDA
3.89 3.79 3.78 2.60 2.50 4.15 4.04 4.29 5.84 5.80 6.01
Long-Term Debt to EBITDA
3.96 3.83 3.80 2.63 2.51 4.16 4.06 3.48 4.70 4.65 4.90
Debt to NOPAT
9.46 9.28 9.20 5.12 4.86 8.24 8.08 8.89 15.83 16.71 19.43
Net Debt to NOPAT
9.30 9.16 9.15 5.06 4.84 8.21 8.04 8.81 15.74 16.61 18.90
Long-Term Debt to NOPAT
9.46 9.28 9.20 5.12 4.86 8.24 8.08 7.15 12.68 13.33 15.40
Altman Z-Score
3.24 3.51 3.35 3.43 3.30 2.39 2.29 2.06 1.89 1.93 1.90
Noncontrolling Interest Sharing Ratio
0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios
- - - - - - - - - - -
Current Ratio
1.04 1.11 1.19 1.24 1.20 1.26 1.26 0.79 0.75 0.77 0.77
Quick Ratio
0.53 0.60 0.67 0.71 0.62 0.65 0.63 0.40 0.37 0.39 0.42
Cash Flow Metrics
- - - - - - - - - - -
Free Cash Flow to Firm (FCFF)
-169 160 144 -8.48 -20 -744 -661 -699 -666 247 273
Operating Cash Flow to CapEx
249.29% 271.03% 155.09% 298.27% 212.63% 300.06% 357.84% 218.56% 260.22% 522.99% 560.47%
Free Cash Flow to Firm to Interest Expense
-20.53 14.18 16.03 -0.98 -2.50 -37.81 -35.03 -38.35 -33.49 10.04 15.30
Operating Cash Flow to Interest Expense
11.21 9.30 7.05 13.12 15.96 6.89 6.93 2.98 6.30 4.37 7.49
Operating Cash Flow Less CapEx to Interest Expense
6.71 5.87 2.50 8.72 8.46 4.60 4.99 1.62 3.88 3.54 6.15
Efficiency Ratios
- - - - - - - - - - -
Asset Turnover
1.51 1.49 1.48 1.49 1.50 1.31 1.31 1.32 1.39 1.24 1.22
Accounts Receivable Turnover
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Inventory Turnover
10.26 9.93 10.13 9.89 9.66 9.08 9.15 9.39 9.57 9.01 8.74
Fixed Asset Turnover
5.62 5.35 5.35 5.36 5.30 5.33 5.37 5.45 5.48 5.61 5.59
Accounts Payable Turnover
7.95 8.13 8.34 8.44 8.90 8.08 8.23 8.65 9.37 8.20 8.14
Days Sales Outstanding (DSO)
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Inventory Outstanding (DIO)
35.58 36.74 36.03 36.91 37.78 40.21 39.89 38.87 38.16 40.49 41.76
Days Payable Outstanding (DPO)
45.90 44.90 43.75 43.26 41.02 45.18 44.35 42.18 38.94 44.52 44.82
Cash Conversion Cycle (CCC)
-10.32 -8.16 -7.72 -6.36 -3.24 -4.97 -4.46 -3.31 -0.78 -4.03 -3.06
Capital & Investment Metrics
- - - - - - - - - - -
Invested Capital
2,614 2,651 2,690 2,697 2,681 3,458 3,421 3,446 3,298 3,267 3,199
Invested Capital Turnover
2.03 1.91 1.88 1.93 1.93 1.66 1.67 1.67 1.76 1.57 1.58
Increase / (Decrease) in Invested Capital
207 -83 -73 77 67 807 731 749 617 -192 -222
Enterprise Value (EV)
5,822 6,411 5,835 6,008 5,582 5,893 5,323 4,805 4,273 3,826 3,675
Market Capitalization
4,560 5,136 4,529 4,717 4,311 3,850 3,330 2,779 2,279 1,862 1,800
Book Value per Share
$6.40 $6.52 $6.56 $6.68 $6.70 $6.71 $6.76 $6.73 $6.17 $6.16 $6.24
Tangible Book Value per Share
$0.08 $0.23 $0.30 $0.44 $0.49 ($3.67) ($1.31) ($3.58) ($1.17) ($3.40) ($3.25)
Total Capital
2,637 2,667 2,697 2,712 2,686 3,466 3,432 3,463 3,310 3,278 3,252
Total Debt
1,285 1,291 1,313 1,305 1,276 2,050 2,004 2,042 2,006 1,976 1,928
Total Long-Term Debt
1,285 1,291 1,313 1,305 1,276 2,050 2,004 1,643 1,607 1,576 1,528
Net Debt
1,263 1,275 1,306 1,290 1,271 2,043 1,993 2,026 1,994 1,964 1,875
Capital Expenditures (CapEx)
37 39 41 38 61 45 37 25 48 21 24
Debt-free, Cash-free Net Working Capital (DFCFNWC)
6.03 50 106 124 103 139 140 177 140 162 115
Debt-free Net Working Capital (DFNWC)
29 66 113 139 108 147 151 194 153 173 168
Net Working Capital (NWC)
29 66 113 139 108 147 151 -206 -247 -227 -232
Net Nonoperating Expense (NNE)
2.96 4.14 3.55 3.54 3.37 10 11 11 17 14 10
Net Nonoperating Obligations (NNO)
1,263 1,275 1,306 1,290 1,271 2,043 1,993 2,026 1,994 1,964 1,875
Total Depreciation and Amortization (D&A)
37 48 37 37 37 49 40 40 38 52 39
Debt-free, Cash-free Net Working Capital to Revenue
0.12% 0.98% 2.07% 2.42% 2.01% 2.74% 2.75% 3.45% 2.67% 3.06% 2.21%
Debt-free Net Working Capital to Revenue
0.56% 1.29% 2.21% 2.71% 2.11% 2.88% 2.97% 3.77% 2.90% 3.28% 3.22%
Net Working Capital to Revenue
0.56% 1.29% 2.21% 2.71% 2.11% 2.88% 2.97% -4.01% -4.70% -4.30% -4.44%
Earnings Adjustments
- - - - - - - - - - -
Adjusted Basic Earnings per Share
$0.17 $0.35 $0.32 $0.31 $0.20 $0.25 $0.28 $0.19 ($0.32) $0.20 $0.19
Adjusted Weighted Average Basic Shares Outstanding
211.63M 211.08M 211.36M 210.82M 211.02M 211.19M 211.39M 211.42M 211.34M 211.87M 212.13M
Adjusted Diluted Earnings per Share
$0.17 $0.34 $0.32 $0.31 $0.20 $0.25 $0.28 $0.19 ($0.32) $0.20 $0.19
Adjusted Weighted Average Diluted Shares Outstanding
213.36M 212.11M 212.32M 211.98M 212.14M 212.14M 211.99M 212.11M 212.11M 212.58M 212.49M
Adjusted Basic & Diluted Earnings per Share
$0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding
210.57M 211.14M 210.60M 210.60M 210.84M 211.14M 211.18M 211.18M 211.55M 211.99M 212.06M
Normalized Net Operating Profit after Tax (NOPAT)
44 81 76 72 47 69 69 55 45 57 51
Normalized NOPAT Margin
3.87% 5.11% 6.24% 6.04% 4.22% 4.46% 5.59% 4.45% 3.69% 3.63% 4.29%
Pre Tax Income Margin
4.08% 6.09% 7.38% 7.18% 5.12% 4.58% 6.31% 4.25% -7.04% 3.82% 4.55%
Debt Service Ratios
- - - - - - - - - - -
EBIT to Interest Expense
6.08 8.99 10.61 10.39 7.52 4.33 4.95 3.65 -3.57 3.24 3.82
NOPAT to Interest Expense
4.71 6.83 7.85 7.89 5.70 3.22 3.68 2.77 -2.50 2.27 2.86
EBIT Less CapEx to Interest Expense
1.58 5.55 6.06 6.00 0.01 2.04 3.01 2.29 -5.99 2.40 2.48
NOPAT Less CapEx to Interest Expense
0.21 3.40 3.31 3.49 -1.81 0.92 1.74 1.40 -4.92 1.43 1.52
Payout Ratios
- - - - - - - - - - -
Dividend Payout Ratio
158.18% 156.84% 154.35% 83.51% 81.83% 89.56% 93.80% 106.99% 249.69% 290.08% 336.32%
Augmented Payout Ratio
195.29% 191.59% 187.12% 99.14% 90.98% 98.03% 96.30% 109.83% 256.25% 295.27% 343.25%

Financials Breakdown Chart

Key Financial Trends

Flowers Foods (NYSE:FLO) shows solid cash generation but weakening profitability. The latest results indicate that the company continues to convert earnings into operating cash and is paying down debt, while revenue, margins and net income have generally deteriorated compared with the prior-year periods. Comparisons with 2025 use the restated figures provided.

  • Operating cash flow remains strong. Flowers Foods generated $133.7 million of operating cash flow in Q2 2026, up from $130.8 million in the restated Q2 2025. First-half 2026 operating cash flow totaled approximately $241.5 million, providing support for capital spending, dividends and debt repayment.
  • Free cash flow was healthy in Q2. After $23.9 million of capital expenditures, estimated free cash flow was approximately $110 million. This represents a strong conversion of operating cash flow and gives the company flexibility to fund shareholder returns and reduce debt.
  • Debt balances have declined modestly. Flowers Foods repaid $41.8 million of debt in Q2 and $81.5 million in Q1. Total debt and capital lease obligations were approximately $1.92 billion at the end of Q2, below roughly $1.98 billion at the end of Q1 2026 and about $2.00 billion at the end of Q2 2025.
  • Cash liquidity improved during the latest quarter. Cash and equivalents increased from $11.5 million at the end of Q1 2026 to $52.8 million at the end of Q2, helped by positive operating cash flow and lower financing outflows.
  • Dividends remain a capital-allocation priority. The company paid $26.6 million in dividends during Q2 and reported a $0.125 quarterly dividend per share. Although dividend payments vary with timing, Flowers Foods has continued making regular shareholder distributions despite recent earnings pressure.
  • Revenue remains seasonal and uneven. Quarterly revenue typically peaks in the first quarter and is lower in the second quarter. Even with that seasonality, Q2 2026 revenue of $1.19 billion declined 2.6% from the restated Q2 2025, while Q1 revenue was roughly flat year over year.
  • The balance sheet contains a large acquisition-related asset base. Goodwill and intangible assets totaled approximately $2.01 billion at the end of Q2 2026, nearly half of total assets. These balances reflect prior acquisitions and could create future impairment risk if acquired businesses underperform, although no impairment charge was recorded in Q1 or Q2 2026.
  • Net income has weakened substantially. Q2 2026 net income fell to $40.7 million, or $0.19 per diluted share, from $58.4 million, or $0.28 per share, in the restated Q2 2025. Q1 2026 earnings also declined approximately 21% year over year, and Q4 2025 included a $136.0 million impairment charge that produced a $67.1 million net loss.
  • Profit margins are under pressure. Q2 2026 gross margin declined to approximately 48.4% from 49.9% in the prior-year quarter, while operating margin fell to about 5.7% from 7.6%. Higher selling, general and administrative expenses relative to revenue contributed to the decline.
  • Short-term liquidity is tight. Current liabilities of $1.02 billion exceeded current assets of $786.3 million at the end of Q2 2026, implying a current ratio of approximately 0.77. Short-term debt was nearly $400 million, making continued operating cash generation and debt refinancing important for financial flexibility.

Overall, the statements present a mixed picture for investors. Flowers Foods has dependable operating cash flow, meaningful free cash flow and evidence of ongoing deleveraging. However, the recent decline in revenue and earnings, compressed margins, sizable acquisition-related assets and sub-1.0 current ratio suggest that the stock’s income and balance-sheet outlook remains dependent on a recovery in operating performance.

09/09/26 03:25 PM ETAI Generated. May Contain Errors.

Flowers Foods Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Flowers Foods' financial year ends in January. Their financial year 2026 ended on January 3, 2026.

In the past 10 years, Flowers Foods' net income has ranged from $83.83 million in 2025 to $248.12 million in 2024, and is currently $83.83 million as of their latest financial filing in 2025. See where experts think Flowers Foods is headed by visiting Flowers Foods' forecast page.

Flowers Foods' total operating income in 2025 was $173.98 million, based on the following breakdown:
  • Total Gross Profit: $2.57 billion
  • Total Operating Expenses: $2.39 billion

Over the last 10 years, Flowers Foods' total revenue changed from $3.78 billion in 2015 to $5.26 billion in 2025, a change of 39.1%.

Flowers Foods' total liabilities were at $2.88 billion at the end of 2025, a 44.7% increase from 2024, and a 79.9% increase since 2015.

In the past 10 years, Flowers Foods' cash and equivalents has ranged from $5.01 million in 2024 to $307.48 million in 2020, and is currently $12.10 million as of their latest financial filing in 2025.

Over the last 10 years, Flowers Foods' book value per share changed from 5.86 in 2015 to 6.17 in 2025, a change of 5.3%.



Financial statements for NYSE:FLO last updated on 8/20/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners